Posted at: 09/11/2012 1:31 PM
Updated at: 09/11/2012 1:43 PM
Print Story
Email to a FriendNew Heart Monitoring Device Approved By FDA
(ABC 6 News) - A remote heart monitoring system, developed in collaboration with Mayo Clinic in Rochester, Minnesota has been given approval by the Food and Drug Administration.
Minnesota based Preventice Inc., was the leading developer of the BodyGuardian Remote Monitoring System. The company says a small body sensor is attached to the patient's chest, which then transmits vital statistics via mobile telephone technology.
The idea is to allows doctors the ability to monitor a patient's key biometrics, while those patients go about their daily lives.
Dr. Charles Bruce, a consultant in cardiovascular disease and internal medicine at Mayo Clinic says, "this platform has the potential to positively impact health-care outcomes."
The FDA approval allows Preventice to now market and sell the BodyGuardian to hospitals and clinics.
More to come on ABC 6 News.
